| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ROMRELL LARRY E | Director | 12300 LIBERTY BOULEVARD, ENGLEWOOD | /s/ Brittany A. Uthoff as Attorney-in-Fact for Larry E. Romrell | 17 Dec 2025 | 0001120556 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FWONK | Series A Liberty Live Common Stock | Other | $0 | -5,163 | -100% | $0.000000 | 0 | 15 Dec 2025 | Direct | F1 |
| transaction | FWONK | Series B Liberty Live Common Stock | Other | $0 | -56 | -100% | $0.000000 | 0 | 15 Dec 2025 | Direct | F1, F2 |
| transaction | FWONK | Series C Liberty Live Common Stock | Other | $0 | -11,572 | -100% | $0.000000 | 0 | 15 Dec 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | FWONK | Stock Option (Right to Buy) - LLYVK | Other | $0 | -103 | -100% | $0.000000 | 0 | 15 Dec 2025 | Series C Liberty Live Common Stock | 103 | $28.89 | Direct | F3 |
| transaction | FWONK | Stock Option (Right to Buy) - LLYVK | Other | $0 | -1,085 | -100% | $0.000000 | 0 | 15 Dec 2025 | Series C Liberty Live Common Stock | 1,085 | $53.46 | Direct | F3 |
| transaction | FWONK | Stock Option (Right to Buy) - LLYVK | Other | $0 | -1,141 | -100% | $0.000000 | 0 | 15 Dec 2025 | Series C Liberty Live Common Stock | 1,141 | $72.91 | Direct | F3 |
| transaction | FWONK | Stock Option (Right to Buy) - LLYVK | Other | $0 | -109 | -100% | $0.000000 | 0 | 15 Dec 2025 | Series C Liberty Live Common Stock | 109 | $27.92 | Direct | F3 |
| transaction | FWONK | Stock Option (Right to Buy) - LLYVK | Other | $0 | -1,162 | -100% | $0.000000 | 0 | 15 Dec 2025 | Series C Liberty Live Common Stock | 1,162 | $44.85 | Direct | F3 |
| transaction | FWONK | Stock Option (Right to Buy) - LLYVK | Other | $0 | -1,152 | -100% | $0.000000 | 0 | 15 Dec 2025 | Series C Liberty Live Common Stock | 1,152 | $33.97 | Direct | F3 |
| transaction | FWONK | Stock Option (Right to Buy) - LLYVK | Other | $0 | -163 | -100% | $0.000000 | 0 | 15 Dec 2025 | Series C Liberty Live Common Stock | 163 | $20.86 | Direct | F3 |
| transaction | FWONK | Stock Option (Right to Buy) - LLYVK | Other | $0 | -1,563 | -100% | $0.000000 | 0 | 15 Dec 2025 | Series C Liberty Live Common Stock | 1,563 | $50.88 | Direct | F3 |
| transaction | FWONK | Stock Option (Right to Buy) - LLYVK | Other | $0 | -144 | -100% | $0.000000 | 0 | 15 Dec 2025 | Series C Liberty Live Common Stock | 144 | $20.03 | Direct | F3 |
| transaction | FWONK | Stock Option (Right to Buy) - LLYVK | Other | $0 | -1,435 | -100% | $0.000000 | 0 | 15 Dec 2025 | Series C Liberty Live Common Stock | 1,435 | $45.33 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | On December 15, 2025, Liberty Media Corporation (the "Issuer") redeemed (the "Redemption") each share of its Series A Liberty Live common stock, Series B Liberty Live common stock and Series C Liberty Live common stock for one share of the corresponding series of Liberty Live Group common stock of Liberty Live Holdings, Inc. ("Liberty Live Holdings"). |
| F2 | Each share of Series B Common Stock is convertible, at the holder's election, into one share of Series A Common Stock, at any time for no consideration other than the surrender of the share of Series B Common Stock for each share of Series A Common Stock. |
| F3 | In connection with the Redemption, all option awards held by the reporting person with respect to the Issuer's Liberty Live common stock (each, a "Live Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the Live Awards were granted, such that each Live Award was exchanged for an option to purchase an equivalent number of shares of the corresponding series of Liberty Live Group common stock of Liberty Live Holdings. |
The transactions and adjustments described above were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended.